1-(4-Bromo-3-chlorophenyl)pyrrolidine

Catalog No. :
ACTRKJ103
CAS No. :
1291487-20-1
Molecular Formula :
C10H11BrClN
Molecular Weight :
260.56

IUPAC Name:1-(4-bromo-3-chlorophenyl)pyrrolidine

1-(4-Bromo-3-chlorophenyl)pyrrolidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$136.00Login to see priceInquiryInquiry
5g98%$370.00Login to see priceInquiryInquiry
10g98%$641.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromo-3-chlorophenyl)pyrrolidine
IUPAC Name1-(4-bromo-3-chlorophenyl)pyrrolidine
MDL No.B181034
Molecular FormulaC10H11BrClN
Molecular Weight260.56
SMILESClC1=CC(N2CCCC2)=CC=C1Br
InChI KeyLOFHFDVFVPSKSD-UHFFFAOYSA-N
Synonym1-(4-Bromo-3-chlorophenyl)pyrrolidine | 1291487-20-1 | 1-Bromo-2-chloro-4-pyrrolidinobenzene | DTXSID30716485 | MFCD18837620 | AKOS015888484 | BS-20642 | Pyrrolidine, 1-(4-bromo-3-chlorophenyl)- | CS-0444185 | A888902
CAS No.1291487-20-1
PubChem CID54758727

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTRKJ103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNZHB157 route compound structure diagram
    ACNZHB157110-52-1 In Stock
  2. Plus
  3. ACWJXU750 route compound structure diagram
    ACWJXU75021402-26-6 In Stock
  4. Then
  5. ACTRKJ103 route product structure diagram
    ACTRKJ1031291487-20-1
Inquiry

2. ACTRKJ103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTFJV468 route compound structure diagram
    ACTFJV4683460-24-0 In Stock
  4. Then
  5. ACTRKJ103 route product structure diagram
    ACTRKJ1031291487-20-1
Inquiry

Comments (0)